ESR1 and atrial fibrillation: Considering these points, the findings of this study suggest that the AF risk may manifest through non-genomic mechanisms of estrogen or other steroid actions mediated by receptors of progesterones, glucocorticoids, or mineralocorticoids, rather than effects through estrogen receptors.